期刊文献+

脑内肾素血管紧张素系统在帕金森病发病机制中的作用 被引量:2

原文传递
导出
摘要 肾素-血管紧张素系统(renin-angiotensin system,RAS)在参与体液水盐平衡和血压调节同时,对心脑血管疾病发生发展起重要作用。随着对脑内RAS的认识深入,诸多证据[1]确定脑内RAS与临床最常见神经变性疾病如Alzheimer病(AD)、
作者 张颖冬
出处 《中华临床医师杂志(电子版)》 2012年第5期12-16,共5页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献2

二级参考文献56

  • 1李卫,何新叶,张宇清.中国四个大规模抗高血压临床试验Meta分析[J].疾病控制杂志,2007,11(1):20-23. 被引量:8
  • 2龚培力.抗高血压药物的评价与研究进展[J].医药导报,2007,26(4):334-339. 被引量:62
  • 3Volpe M, Tocci G. Antihypertensive therapy and cerebrovascular protection[J]. Curr Opin Nephrol Hypertens, 2006,15:498.
  • 4Redon J, Roca-Cusachs A, Mora-Macia J. Uncontrolled early morning blood pressure in medicated patients: the ACAMPA study. Analysis of the control of blood pressure using ambulatory blood pressure monitoring[ J ]. Blood Press Monit, 2002,7 : 111.
  • 5Kario K. Time for focus on morning hypertension: pitfall of current antihypertensive medication[J].Am J Hypertens, 2005,18 : 149.
  • 6Lawes CM, Bennett DA, Feigin VL,et al. Blood pressure and stroke: an overview of published reviews[ J]. Stroke,2004,35:776.
  • 7Aronow WS, Frishman WH. Treatment of hypertension and prevention of ischemic stroke [ J ]. Curr Cardiol Rep, 2004,6 : 124.
  • 8Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events : results of prospectively-designed overviews of randomised trials[ J]. Lancet, 2003,362:1527.
  • 9Hackam DG. Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings : Yes [ J ]. Stroke, 2009,40:3159.
  • 10Schrader J, Kulschewski A, Dendorfer A. Inhibition of the RAS and stroke prevention[J]. Am J Cardiovasc Drugs, 2007,7:25.

共引文献11

同被引文献61

  • 1Mehanna R, Jankovic J. Movement disorders in cerebrovascular disease [ J ]. Lancet Neurol, 2013,12 (6) :597-608.
  • 2Bansil S, Prakash N, Kaye J, et al. Movement disorders after stroke in adults: a review [ DB/OL ]. Tremor Other Hyperkinet Mov, 2012, 2. http://www, tremorjournal. org/article/view/42.
  • 3Handley A, Medcalf P, Hellier K, et al. Movement disorders after stroke [ J ]. Age Ageing, 2009,38 ( 3 ) : 260 -266.
  • 4Siniscalchi A, Gallelli L, Labate A, et al. Post-stroke movement disorders: clinical manifestations and pharmacological management [ J ]. Curr Neuropharmacol,2012,10 ( 3 ) : 254-262.
  • 5Ghika-Schmid F, Ghika J, Regli F, et al. Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry [ J ]. J Neurol Sci, 1997, 146 (2) :109-116.
  • 6Alarc6n F, Zijlmans JCM, Duefias G, et al. Post-stroke movement disorders : report of 56 patients [ J ]. J Neurol Neurosurg Psyehiat, 2004,75 ( 11 ) : 1568-1574.
  • 7van Zagten M, Lodder J, Kessels F. Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions [ J ]. Mov Disord, 1998,13 ( 1 ) :89-95.
  • 8Fohynie T, Barker R, Brayne C. Vascular parkinsonism : a review of the precision and frequency of the diagnosis [ J ]. Neuroepidemio1,2002,21 ( 1 ) :1-7.
  • 9Thanvi B, Lo N, Robinson T. Vascular parkinsonism : an important cause of parkinsonism in older people [ J ]. Age Ageing,2005,34 (2) : 114-119.
  • 10Kim JS. Delayed onset mixed involuntary movements after thalamic stroke. Clinical, radiological and pathophysiological findings [ J ]. Brain, 2001,124 ( Pt 2 ) : 299-309.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部